Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Transcutaneous Posterior Tibial Nerve Stimulation Therapy for the Management of Patients With Premature Ejaculation. Phase III Clinical Trial

NCT06425224 is registered in ClinicalTrials.gov with Boston Medical Group as lead sponsor.

NCT NCT06425224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06425224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Transcutaneous Posterior Tibial Nerve Stimulation Therapy for the Management of Patients With Premature Ejaculation. Phase III Clinical Trial
Lead sponsor
Boston Medical Group
Phase
Phase 3
Overall status
Recruiting
Start date
June 15, 2022
Completion date
June 30, 2025
Enrollment
129 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature ejaculation, sex disorder, ten